These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3705010)

  • 1. Increased in vitro platelet aggregation in hypertriglyceridemias.
    Riess H; Merk W; Falkner C; Hiller E
    Thromb Res; 1986 Feb; 41(3):281-9. PubMed ID: 3705010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Functional status of thrombocytes and the anti-aggregative activity of the vascular wall in dyslipoproteinemias and ischemic heart disease].
    Mikhailova IA; Lipovetskiĭ BM; Magracheva EIa; Gurevich VS
    Ter Arkh; 1989; 61(2):101-4. PubMed ID: 2727909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical evaluation of platelet aggregation in whole human blood.
    Riess H; Braun G; Brehm G; Hiller E
    Am J Clin Pathol; 1986 Jan; 85(1):50-6. PubMed ID: 3079628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of type IIa, IIb and IV-hyperlipoproteinemia on platelet prostaglandin sensitivity, plasma thromboxane B2 and platelet half-life.
    Strobl-Jäger E; Widhalm K; Sinzinger H
    Prostaglandins Leukot Med; 1986 Nov; 25(1):39-47. PubMed ID: 3540998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary soya lecithin decreases plasma triglyceride levels and inhibits collagen- and ADP-induced platelet aggregation.
    Brook JG; Linn S; Aviram M
    Biochem Med Metab Biol; 1986 Feb; 35(1):31-9. PubMed ID: 3778675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatty acid composition of platelets and of plasma lipid esters in relation to platelet function in patients with ischaemic heart disease.
    Boberg M; Vessby B; Croon LB
    Atherosclerosis; 1985 Dec; 58(1-3):49-63. PubMed ID: 2936356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study of phospholipids in primary hyperlipoproteinemias].
    Kuczyńska K
    Pol Arch Med Wewn; 1979 Jul; 62(1):29-40. PubMed ID: 503884
    [No Abstract]   [Full Text] [Related]  

  • 8. Platelet aggregation in human whole blood after chronic administration of aspirin.
    de la Cruz JP; Camara S; Bellido I; Carrasco T; Sanchez de la Cuesta F
    Thromb Res; 1987 Apr; 46(1):133-40. PubMed ID: 3109069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chylomicrons from patients with type V hyperlipoproteinemia inhibit platelet function.
    Aviram M; Furman B; Brook JG
    Atherosclerosis; 1985 Aug; 56(2):157-67. PubMed ID: 4074453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemorrheologic abnormalities in defined primary dyslipoproteinemias with both high and low atherosclerotic risks.
    Otto C; Ritter MM; Richter WO; Minkenberg R; Schwandt P
    Metabolism; 2001 Feb; 50(2):166-70. PubMed ID: 11229424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rheological properties and membrane fluidity of red blood cells and platelets in primary hyperlipoproteinemia.
    Muller S; Ziegler O; Donner M; Drouin P; Stoltz JF
    Atherosclerosis; 1990 Aug; 83(2-3):231-7. PubMed ID: 2242099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased platelet sensitivity and thromboxane B2 formation in type-II hyperlipoproteinaemic patients.
    Tremoli E; Maderna P; Colli S; Morazzoni G; Sirtori M; Sirtori CR
    Eur J Clin Invest; 1984 Oct; 14(5):329-33. PubMed ID: 6437830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of aggregating agents and of blood cells on the aggregation of whole blood by impedance technique.
    Mannucci L; Redaelli R; Tremoli E
    Thromb Res; 1988 Oct; 52(2):143-51. PubMed ID: 3194889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fibrinolytic capacity after exertion in atherogenic hyperlipoproteinemias].
    Zdrenghea D; Mărcuşu C; Cucuianu M; Rentsch S
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1979; 31(5):435-40. PubMed ID: 44567
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of platelet aggregation using light transmission and multiple electrode aggregometry in Glanzmann thrombasthenia.
    Awidi A; Maqablah A; Dweik M; Bsoul N; Abu-Khader A
    Platelets; 2009 Aug; 20(5):297-301. PubMed ID: 19548178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo platelet activity and lipoprotein patterns in coronary artery disease.
    Goubran F; Maklady F; Saad M; el-Ashry M
    Wien Klin Wochenschr; 1986 Apr; 98(7):209-11. PubMed ID: 3705598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Composition of VLDL, LDL and HDL lipoprotein fractions in type IIa, IIb, III, IV, and V hyperlipemia patients in comparison with healthy individuals].
    Hutt V; Klör HU; Wechsler JG; Ditschuneit H
    J Clin Chem Clin Biochem; 1984 Feb; 22(2):141-6. PubMed ID: 6716054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro effect of endothelin-1 on collagen, and ADP-induced aggregation in human whole blood and platelet rich plasma.
    Knöfler R; Urano T; Malyszko J; Takada Y; Takada A
    Thromb Res; 1995 Jan; 77(1):69-78. PubMed ID: 7701479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of sex difference on platelet aggregation using an optical method in healthy subjects.
    Beyan C; Kaptan K; Ifran A; Savaşçi S; Oztürk Y; Okmen B
    Clin Lab Haematol; 2006 Feb; 28(1):14-6. PubMed ID: 16430454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of cefonicid on platelet aggregation.
    Cazzola M; Santangelo G; Paizis G; Matera C; Rossi F
    Drugs Exp Clin Res; 1991; 17(2):105-8. PubMed ID: 1864223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.